A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: An ASSENT-2 ECG/VCG substudy

European Heart Journal

Volumn 26, Issue 17, 2005, Pages 1726-1733

  Johanson, Per ^a,b   Fu, Yuling ^c   Goodman, Shaun G ^d   Dellborg, Mikael ^a   Armstrong, Paul W ^c   Krucoff, Mitchell W ^b   Wallentin, Lars ^e   Wagner, Galen S ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ECG; Fibrinolysis; Infarct size; Myocardial infarction

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; FORECASTING; HEART INFARCTION; HEART MUSCLE; HUMAN; HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REPERFUSION; RISK ASSESSMENT; ST SEGMENT ELEVATION;

AGED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TIME FACTORS; VECTORCARDIOGRAPHY;

EID: 24044454060     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi221     Document Type: Article

References (37)

1. Aldrich HR, Wagner NB, Boswick J et al. Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts. Am J Cardiol 1988;61:749-753.
2. Clemmensen P, Grande P, Aldrich HR et al. Evaluation of formulas for estimating the final size of acute myocardial infarcts from quantitative ST-segment elevation on the initial standard 12-lead ECG. J Electrocardiol 1991;24:77-83.
3. Wilkins ML, Pryor AD, Maynard C et al. An electrocardiographic acuteness score for quantifying the timing of a myocardial infarction to guide decisions regarding reperfusion therapy. Am J Cardiol 1995;75:617-620.
4. Corey KE, Maynard C, Pahlm O et al. Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation. Am J Cardiol 1999;83:826-831.
5. Hackett D, Davies G, Chierchia S et al. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987;317:1055-1059.
6. Krucoff MW, Croll MA, Pope JE et al. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol 1993;71:145-151.
7. Dellborg M, Steg PG, Simoons M et al. Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. Eur Heart J 1995;16:21-29.
8. Santoro GM, Valenti R, Buonamici P et al. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 1998;82:932-937.
9. van't Hof AW, Liem A, Suryapranata H et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myo-cardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-2306.
10. Schroder R, Dissmann R, Bruggemann T et al. Extent of early STsegment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 1994;24:384-391.
11. van't Hof AW, Liem A, de Boer MJ et al. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 1997;350:615-619.
12. Johanson P, Svensson AM, Dellborg M. Clinical implications of early ST-segment variability. A report from the ASSENT 2 ST-monitoring substudy. Coron Artery Dis 2001;12:277-283.
13. Johanson P, Jernberg T, Gunnarsson G et al. Prognostic value of ST-segment resolution-when and what to measure. Eur Heart J 2003;24:337-345.
14. Reimer KA, Lowe JE, Rasmussen MM et al. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-794.
15. Wagner G, Fu Y, Goodman S et al. How does ST-segment resolution one-hour after fibrinolysis for acute myocardial infarction predict final infarct size? Insights from ASSENT 3. Eur Heart J 2002;23(Suppl.):266.
16. Dong J, Ndrepepa G, Schmitt C et al. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation 2002;105:2946-2949.
17. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Lancet 1999;354:716-722.
18. Selvester RH, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size. The development and application of the system. Arch Intern Med 1985;145:1877-1881.
19. Johanson P, Swedberg K, Dellborg M. ST variability during the first 4 hours of acute myocardial infarction predicts 1-year mortality. Ann Noninvasive Electrocardiol 2001;6:198-202.
20. Johanson P, Wallentin L, Nilsson T et al. ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy. Am Heart J 2004;147:853-858.
21. Feldman LJ, Himbert D, Juliard JM et al. Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size. J Am Coll Cardiol 2000;35:1162-1169.
22. Steg PG, Dellborg M, Simoons M. Transient exacerbation of ST-segment elevation upon reperfusion in acute myocardial infarction. J Electrocardiol 1993;26(Suppl.):156.
23. Naslund U, Haggmark S, Johansson G et al. Quantification of myocardium at risk and detection of reperfusion by dynamic vectorcardiographic ST segment monitoring in a pig occlusion-reperfusion model. Cardiovasc Res 1993;27:2170-2178.
24. Raitt MH, Maynard C, Wagner GS et al. Relation between symptom duration before thrombolytic therapy and final myocardial infarct size. Circulation 1996;93:48-53.
25. Andrews J, Straznicky IT, French JK et al. ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. Circulation 2000;101:2138-2143.
26. Moons KG, Klootwijk P, Meij SH et al. Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial. Am Heart J 1999;138:525-532.
27. Shah A, Wagner GS, Granger CB et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol 2000;35:666-672.
28. Miida T, Oda H, Toeda T et al. Additional ST-segment elevation immediately after reperfusion and its effect on myocardial salvage in anterior wall acute myocardial infarction. Am J Cardiol 1994;73:851-855.
29. Kobayashi N, Ohmura N, Nakada I et al. Further ST elevation at reperfusion by direct percutaneous transluminal coronary angioplasty predicts poor recovery of left ventricular systolic function in anterior wall AMI. Am J Cardiol 1997;79:862-866.
30. Dellborg M, Riha M, Swedberg K. Dynamic QRS-complex and ST-segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy. The TEAHAT Study Group. Am J Cardiol 1991;67:343-349.
31. Kwon K, Freedman SB, Wilcox I et at. The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion. Am J Cardiol 1991;67:109-115.
32. Langer A, Krucoff MW, Klootwijk P et al. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. J Am Coll Cardiol 1998;31:783-789.
33. Baskin JM, Wilkins ML, Ohman EM et al. Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1993;71:1362-1365.
34. Jurlander B, Holmvang L, Galatius S et al. 'Mirror-lake' serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction. Am Heart J 2003;146:757-763.
35. De Lemos JA, Antman EM, Giugliano RP et al. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. Am Heart J 2000;140:373-378.
36. Johanson P, Rossberg J, Dellborg M. Continuous ST monitoring: a bedside instrument? A report from the Assessment of the Safety of a New Thrombolytic (ASSENT 2) ST monitoring substudy. Am Heart J 2001;142:58-62.
37. Fesmire FM, Hughes AD, Fody EP et al. The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes. Ann Emerg Med 2002;40:584-594.